← Eichor
Study identifier: NCT06905015 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

Condition: Liver Tumor; Surgery · Primary Liver Tumor, Metastatic Liver · Primary Liver Cancer  ·  Sponsor: Warangkana Lapisatepun

PhaseNA
Planned participants74
Who can joinAll sexes, 20 Years to 70 Years
Healthy volunteersNo

About this study

Liver resection is a major surgery that can be associated with significant intraoperative blood loss and blood transfusion. Among high-volume centers, median intraoperative blood loss ranges between 300-800 ml. Excessive blood loss is a strong independent predictor of worsened postoperative outcomes, increasing morbidity and mortality rates by 20%-35%. Additionally, perioperative allogeneic blood transfusions are associated with deleterious outcomes, including tumor recurrence and increased rates of complications and death. The liver is a highly vascular organ with minimal vascular resistance, receiving up to 25% of cardiac output and pooling 20% of the splanchnic blood. Hepatic veins are a common source of venous hemorrhage. The pressure in the hepatic veins is directly correlated with the pressure in the vena cava and reducing cardiac preload results in decreased hepatic vein congestion. Therefore, low central venous pressure anesthesia (typically below 5 mmHg) can reduce the pressure gradient for retrograde venous bleeding, facilitate the outflow of blood from hepatic veins, and decrease blood volume and pressure in the liver. This anesthetic method is the standard technique to minimize blood loss during liver resection. Central venous pressure was the static parameter used to indicate the right ventricular end-diastolic volume index (RVEDI) and was believed to be correlated with volume status. Despite this, central venous pressure did not reliably predict preload respon…

This description comes directly from the study's public registry record.

Talk to the study team

Worakitti Lapisatepun, MD. PhD.  ·  0910688761  ·  worakitti.l@cmu.ac.th

Worakitti Lapisatepun, MD.  ·  0910688761  ·  worakitti.l@cmu.ac.th

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Anesthesiology, Faculty of Medicine, Chiang Mai UniversityChiang Mai, Chiangmai, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06905015